HROW
Harrow, Inc. Common Stock#56 · 2024EPBYearly return
+181%
Peak return
+396%
Max drawdown
-45%
ADR (20 days)
+5.1%
Base
7 days / -18.6%
Prior run
+166%
Breakout volume
12.9x
Pivot
$26.21
Catalyst FDA/Clinical2024-07-19Nicox announces attendance at upcoming conferences - GlobeNewswireGlobeNewswire Inc.
Biotech-/Medtech-News mit binaerem Daten-, Zulassungs- oder Studiencharakter.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare HROW with the current market directly.